Prevalence of current tobacco use in Naoero
Naoero: Prevalence of current tobacco use was 34.8% in 2024. ▼ Falling
Prevalence of current tobacco use in Naoero, 2000–2024
Source: Global Health Observatory Data Repository, World Health Organization (WHO). Measured in % of adults.
Analysis
The most recent figure for prevalence of current tobacco use in Naoero is 34.8%, measured in 2024. That is the lowest value across all 9 years on record.
That represents a change of down 2.8% on the previous year and down 20.9% over ten years.
Over the whole period, prevalence of current tobacco use in Naoero peaked at 66.1% in 2000 and was at its lowest, 34.8%, in 2024.
That places Naoero 14th out of 166 countries with data for 2024, putting it in the top 10%.
Prevalence of current tobacco use in Naoero, year by year
| Year | % of adults | Change |
|---|---|---|
| 2000 | 66.1% | — |
| 2005 | 57.4% | -13.2% |
| 2007 | 54.5% | -5.1% |
| 2010 | 50.2% | -7.9% |
| 2015 | 44.0% | -12.4% |
| 2020 | 38.5% | -12.5% |
| 2022 | 36.6% | -4.9% |
| 2023 | 35.8% | -2.2% |
| 2024 | 34.8% | -2.8% |
Naoero compared with similar countries
- Naoero's 34.8% is above the median for high income countries, which is 21.2%, 1.6× the median. (57 countries reporting)
- Naoero's 34.8% is above the median for East Asia & Pacific, which is 23.1%, 1.5× the median. (29 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 59.3% | 54.5% | 66.1% | 3 |
| 2010s | 47.1% | 44.0% | 50.2% | 2 |
| 2020s | 36.4% | 34.8% | 38.5% | 4 |
Countries ranked near Naoero
More health data for Naoero
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8477 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,118 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2019)
- Population ages 00-04, female, annual growth rate -2.33 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0593 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.1333 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is prevalence of current tobacco use in Naoero?
- Prevalence of current tobacco use in Naoero was 34.8% in 2024, according to Global Health Observatory Data Repository, World Health Organization (WHO).
- What is the highest prevalence of current tobacco use recorded in Naoero?
- The highest recorded value was 66.1% in 2000.
- What is the lowest prevalence of current tobacco use recorded in Naoero?
- The lowest recorded value was 34.8% in 2024.
- How does Naoero rank for prevalence of current tobacco use?
- Naoero ranks 14th out of 166 countries with data for 2024.
- Is prevalence of current tobacco use rising or falling in Naoero?
- Over the last ten years it is down 20.9%. The long-run trend across the full record is falling.
- Where does this Naoero data come from?
- The figures come from Global Health Observatory Data Repository, World Health Organization (WHO), published as part of Prevalence of current tobacco use (% of adults). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.